Avidity Biosciences secures $400 million in private placement

Published on 29 Feb 2024 on Investing.com

Avidity Biosciences, Inc. (NASDAQ: RNA), a biopharmaceutical company specializing in RNA...

Read the rest of the article

Start tracking your investments with Statfolio

President and CEO Sarah Boyce of Avidity Biosciences Inc (NASDAQ:RNA) sold 28,000 shares of the c...

GuruFocus.com via Yahoo Finance 4 Apr 2024

Michael Maclean, Chief Financial Officer of Avidity Biosciences Inc (NASDAQ:RNA), sold 40,000 sha...

GuruFocus.com via Yahoo Finance 15 Mar 2024

Shares of Bitdeer Technologies Group BTDR rose sharply during Monday’s session after the compan...

Benzinga 4 Mar 2024

Monday, Avidity Biosciences Inc RNA revealed new long-term AOC 1001 data from the MARINA open-lab...

Benzinga 4 Mar 2024

As of Feb. 29, 2024, three stocks in the health care sector could be flashing a real warning to i...

Benzinga 1 Mar 2024

Avidity Biosciences, Inc. (NASDAQ: RNA), a biopharmaceutical company specializing in RNA...

Investing.com 29 Feb 2024

Avidity Biosciences, Inc. (RNA) came out with a quarterly loss of $0.79 per share versus the Zack...

Zacks via Yahoo Finance 28 Feb 2024

Avidity Biosciences, Inc. (RNA) shares ended the last trading session 15% higher at $12.04. The j...

Zacks via Yahoo Finance 29 Jan 2024

For Immediate Release Chicago, IL – December 1, 2023 – Zacks.com announces the list of stocks fea...

Zacks via Yahoo Finance 1 Dec 2023

Shares of Elbit Systems Ltd. (ESLT) declined 2.2% after the company reported third-quarter 2023 e...

Zacks via Yahoo Finance 29 Nov 2023